日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab

肝细胞癌的病因可能影响阿特珠单抗-贝伐珠单抗治疗下的疾病进展模式

Stefanini, Bernardo; Piscaglia, Fabio; Marra, Fabio; Iavarone, Massimo; Vivaldi, Caterina; Cabibbo, Giuseppe; Palloni, Andrea; Pressiani, Tiziana; Dalbeni, Andrea; Stefanini, Benedetta; Stella, Leonardo; Federico, Piera; Svegliati-Baroni, Gianluca; Lonardi, Sara; Soldà, Caterina; Ielasi, Luca; De Lorenzo, Stefania; Garajova, Ingrid; Campani, Claudia; Bruccoleri, Mariangela; Masi, Gianluca; Celsa, Ciro; Brandi, Giovanni; Auriemma, Alessandra; Daniele, Bruno; Ponziani, Francesca Romana; Lani, Lorenzo; Chen, Rusi; Boe, Maria; Granito, Alessandro; Rimassa, Lorenza; Tovoli, Francesco

Multidisciplinary Clinic Approach Improves Immunotherapy Treatment Outcomes in Unresectable Hepatocellular Carcinoma: A Multicentre Retrospective Study

多学科诊疗模式改善不可切除肝细胞癌的免疫治疗效果:一项多中心回顾性研究

Dalbeni, Andrea; Auriemma, Alessandra; Vicardi, Marco; Cattazzo, Filippo; Bellucco, Maria Elena; Mazzarelli, Chiara; Villa, Federica; Dispinzieri, Giulia; Natola, Leonardo Antonio; Soldà, Caterina; Lonardi, Sara; Foltran, Luisa; Torresan, Sara; Rota, Simone; Pressiani, Tiziana; Rimassa, Lorenza; Sacerdoti, David; Milella, Michele

From algorithms to adaptive frameworks: from square to circle in hepatocellular carcinoma management

从算法到自适应框架:肝细胞癌管理中的方正转变

Vitale, Alessandro; Cabibbo, Giuseppe; Bargellini, Irene; Rimassa, Lorenza; Cillo, Umberto

Navigating second-line therapy after immunotherapy in advanced HCC☆

晚期肝细胞癌免疫治疗后二线治疗的策略☆

Vogel, Arndt; Saborowski, Anna; Rimassa, Lorenza; El-Khoueiry, Anthony

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study

度伐利尤单抗联合或不联合曲美利尤单抗治疗肝细胞癌在临床实践中具有可重复的安全性和有效性:DT-real 研究结果

Celsa, Ciro; Pressiani, Tiziana; Nishida, Naoshi; Chamseddine, Shadi Mohamad; Arvind, Ashwini; Li, Michael; Fortuny, Marta; Khaled, Najib Ben; Iavarone, Massimo; Toyoda, Hidenori; Rapposelli, Ilario Giovanni; Casadei-Gardini, Andrea; Vivaldi, Caterina; Ulahannan, Susanna; Andanamala, Haripriya; Scheiner, Bernhard; Pinter, Matthias; Orlandi, Elena; Fulgenzi, Claudia A M; Manfredi, Giulia F; Lombardi, Pasquale; D'Alessio, Antonio; Stefanini, Bernardo; Villani, Rosanna; Ponziani, Francesca Romana; Stella, Leonardo; Carminati, Ornella; Ricci, Angela Dalia; Gonzalez, Melina; Sparacino, Alba; Di Maria, Gabriele; Vaccaro, Marco; Cabibbo, Giuseppe; Cammà, Calogero; Reig, Maria; Kelley, Robin K; Singal, Amit G; Kaseb, Ahmed O; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David James

Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data From the LOR-HCC (Lombardy Real-World HCC Group)

Durvalumab-Tremelimumab治疗晚期肝细胞癌:来自LOR-HCC(伦巴第真实世界肝细胞癌研究组)的真实世界数据

Casadei-Gardini, Andrea; Canova, Lorenzo; Tosi, Federica; Camera, Silvia; Bocchero, Elisa; Pozzoni, Pietro; Torchio, Martina; Corallo, Salvatore; Costantino, Daniela; Stagno, Annamaria; Grizzi, Giulia; Gengarle, Rita; Tomasello, Gianluca; Ansarin, Nasim; Bruccoleri, Mariangela; Bencardino, Katia; Persano, Mara; Pino, Martina; Riva, Alessia; Vavassori, Sara; Argiento, Lorenzo; Mazzarelli, Chiara; De Giorgio, Massimo; Caremoli, Elena Rota; Rimini, Margherita; Pressiani, Tiziana; Rimassa, Lorenza; Iavarone, Massimo

The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and Diabetes

二甲双胍对肝细胞癌合并糖尿病患者接受阿特珠单抗/贝伐珠单抗治疗的影响

Dalbeni, Andrea; Vicardi, Marco; Natola, Leonardo A; Auriemma, Alessandra; Stefanini, Bernardo; Vivaldi, Caterina; Federico, Piera; Polloni, Andrea; Soldà, Caterina; Lani, Lorenzo; Garajová, Ingrid; Tamberi, Stefano; De Lorenzo, Stefania; Piscaglia, Fabio; Di Maria, Vincenzo; Masi, Gianluca; Lonardi, Sara; Brandi, Giovanni; Daniele, Bruno; Trevisani, Franco; Svegliati-Baroni, Gianluca; Schiada, Laura; Marra, Fabio; Campani, Claudia; Celsa, Ciro; Cabibbo, Giuseppe; Bruccoleri, Mariangela; Iavarone, Massimo; Stella, Leonardo; Ponziani, Francesca R; Pressiani, Tiziana; Rimassa, Lorenza; Tovoli, Francesco; Sacerdoti, David

Does adjuvant therapy improve survival in patients undergoing pancreaticoduodenectomy for distal cholangiocarcinoma? A systematic review, meta-analysis and meta-regression

辅助治疗能否提高接受胰十二指肠切除术治疗远端胆管癌患者的生存率?一项系统评价、荟萃分析和荟萃回归研究

Nappo, G; D'Ambra, V; Ricci, C; Pagnanelli, M; Rebasti, V; Alves, G; Crippa, S; Rimassa, L; Casadei, R; Zerbi, A

Mapping the landscape of biliary tract cancer in Europe: challenges and controversies

欧洲胆道癌概况:挑战与争议

Rimassa, Lorenza; Khan, Shahid; Groot Koerkamp, Bas; Roessler, Stephanie; Andersen, Jesper B; Raggi, Chiara; Lleo, Ana; Nault, Jean-Charles; Calderaro, Julien; Gabbi, Chiara; Kather, Jakob N; Banales, Jesus M; Bargellini, Irene; Morement, Helen; Krawczyk, Marcin; Farazi, Paraskevi A; Carpino, Guido; Avila, Matias A; Saborowski, Anna; Cardinale, Vincenzo; Braconi, Chiara; Macias, Rocio I R

Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]

对“晚期胆道癌的新系统治疗模式及欧洲患者就医机会的差异”一文的更正[《柳叶刀区域健康 - 欧洲》,第 50 卷,2025 年 3 月,101170]

Rimassa, Lorenza; Lamarca, Angela; O'Kane, Grainne M; Edeline, Julien; McNamara, Mairéad G; Vogel, Arndt; Fassan, Matteo; Forner, Alejandro; Kendall, Timothy; Adeva, Jorge; Casadei-Gardini, Andrea; Fornaro, Lorenzo; Hollebecque, Antoine; Lowery, Maeve A; Macarulla, Teresa; Malka, David; Mariamidze, Elene; Niger, Monica; Ustav, Anu; Bridgewater, John; Macias, Rocio I R; Braconi, Chiara